Table 4.
Prevalence of abnormal imaging and biomarker results according to diabetes duration
| Quartile; Diabetes duration (y) | n | NTpBNP 125 pg/mL n (%) | GLS ≥ -16% n (%) | E/e’ ≥ 14 n (%) | e’ < 8 cm/s n (%) | LAVi > 34 ml/m2 n (%) | LVMi > 88 g/m2 (F), > 102 g/m2 (M) n (%) |
|---|---|---|---|---|---|---|---|
| < 6 | 206 | 28 (13) | 36 (18) | 23 (11) | 143 (67) | 94 (44) | 32 (15) |
| 7–10 | 164 | 26 (15) | 25 (16) | 18 (11) | 117 (68) | 70 (41) | 26 (15) |
| 11–16 | 177 | 27 (15) | 24 (14) | 29 (16) | 127 (70) | 75 (41) | 19 (10) |
| > 16 | 175 | 39 (21) | 36 (20) | 45 (23) | 143 (73) | 102 (52) | 30 (15) |
| p value | 0.194 | 0.494 | 0.001 | 0.543 | 0.095 | 0.473 |
GLS global longitudinal strain, LAVi left atrial volume indexed to body surface area, LVMi left ventricular mass indexed to body surface area